Provexis (LSE:PXS) OCF Margin %: -51.65% (As of Sep. 2025)


What is Provexis OCF Margin %?

Provexis LSE:PXS +11.11% OCF Margin % is -51.65% as of Sep. 2025. The stock has 1 warning sign investors should review. Among 956 Drug Manufacturers companies, Provexis ranks worse than 91.42% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Provexis's Cash Flow from Operations for the six months ended in Sep. 2025 was £-0.19 Mil. Provexis's Revenue for the six months ended in Sep. 2025 was £0.36 Mil. Therefore, Provexis's OCF Margin % for the quarter that ended in Sep. 2025 was -51.65%.

As of today, Provexis's current OCF Yield % is -1.86%.

The historical rank and industry rank for Provexis's OCF Margin % or its related term are showing as below:

LSE:PXS' s OCF Margin % Range Over the Past 10 Years
Min: -397.83   Med: -107.76   Max: -23.82
Current: -62.69

During the past 13 years, the highest OCF Margin % of Provexis was -23.82%. The lowest was -397.83%. And the median was -107.76%.

LSE:PXS's OCF Margin % is ranked worse than
91.42% of 956 companies
in the Drug Manufacturers industry
Industry Median: 9.985 vs LSE:PXS: -62.69

Provexis OCF Margin % Related Terms

Provexis OCF Margin % Historical Data

* Premium members only.

The historical data trend for Provexis's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Provexis OCF Margin % Chart

Provexis Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.88 -50.23 -133.59 -23.82 -26.39

Provexis Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.72 -31.40 2.17 -70.61 -51.65

LSE:PXS vs ZTS, UTHR, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Provexis OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Provexis's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Provexis's OCF Margin % falls into.


Provexis OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Provexis's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-0.341/1.292
=-26.39 %

Provexis's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.188/0.364
=-51.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -51.65% mean?
Provexis (LSE:PXS) has a OCF Margin % of -51.65% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Provexis and its competitors. According to the industry distribution chart, Provexis ranks #874 out of 956 companies in the Drug Manufacturers industry, placing it in the top 91.4%.
Is Provexis' OCF Margin % too high?
Provexis' current OCF Margin % is -51.65%. Based on the distribution chart, Provexis ranks #874 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Provexis' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Provexis ranks #874 out of 956 companies for OCF Margin %. This places Provexis in the lower half of its industry. The industry median OCF Margin % is 9.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Provexis and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Provexis's current OCF Margin % is -51.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Provexis stock overvalued right now?
Provexis (LSE:PXS) has a current OCF Margin % of -51.65%. The current OCF Margin % is -51.65%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Provexis (LSE:PXS), the current OCF Margin % is -51.65% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Provexis Business Description

Other Exchanges PXSl:UKNZCA:Germany
Address 2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Provexis PLC is engaged in developing, licensing and selling the proprietary, scientific Fruitflow heart-health functional food ingredient for the global functional food sector. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.